Format

Send to

Choose Destination
Acta Neuropathol. 2018 Mar;135(3):481-484. doi: 10.1007/s00401-018-1808-0. Epub 2018 Jan 25.

cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC).

Author information

1
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. dlouis@mgh.harvard.edu.
2
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
3
Department of Pathology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
4
University Medical Center Utrecht, Utrecht, The Netherlands.
5
Institute of Neuropathology, University Hospital Münster, Pottkamp 2, 48149, Münster, Germany.
6
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
7
Departments of Neurology, Radiation Oncology and Division of Hematology/Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
8
Charbonneau Cancer Institute, University of Calgary, Calgary, AB, T2N4Z6, Canada.
9
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
10
Department of Neuropathology, Berlin Institute of Health, Berlin, Germany.
11
Aix-Marseille Univ, APHM, Inserm, CRO2 UMR_S 911, Hôpital de la Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
12
Departments of Pathology and Neurological Surgery, University of Virginia, Charlottesville, VA, 22908, USA.
13
Neurology Clinic and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) Core Center Heidelberg, Heidelberg, Germany.
14
The Brain Tumor Center at Erasmus MC Cancer Center, Rotterdam, The Netherlands.
PMID:
29372318
DOI:
10.1007/s00401-018-1808-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center